Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Feb 20, 2014

30339_dirs_2014-02-20_d65c9a0c-94bf-474f-89e3-90e7bc5fee65.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-02-18

Reporting Person: FEDERICI WILLIAM J (Sr. VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-18 Common Stock A 12293.0000 $48.6900 Acquired 205614.8226 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1015.2354 Indirect
Common Stock 3870.3776 Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2011 that have vested for performance period 10.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.